Michelle A. Moorhouse

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

The burden of HIV-related stigma on clinical and quality of life outcomes: results from a systematic literature review.

The burden of HIV-related stigma on clinical and quality of life outcomes: results from a systematic literature review.

Journal: Health psychology and behavioral medicine

Published: July 31, 2026

Health Disparities Among Children Who Are HIV-Exposed but Without HIV: A Narrative Literature Review and Call to Action for Further Research.

Health Disparities Among Children Who Are HIV-Exposed but Without HIV: A Narrative Literature Review and Call to Action for Further Research.

Journal: Cureus

Published: December 06, 2025

The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis.

The Effect of Rifampicin on the Plasma and Intracellular Pharmacokinetics of Tenofovir Alafenamide Fumarate in HIV-associated Tuberculosis.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: June 18, 2025

Dolutegravir + lamivudine effectiveness and tolerability in real-world cohorts with HIV-1 across Asia and South America: A systematic literature review.

Dolutegravir + lamivudine effectiveness and tolerability in real-world cohorts with HIV-1 across Asia and South America: A systematic literature review.

Journal: Medicine

Published: April 07, 2025

DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.

DORA: 48-week weight and metabolic changes in Black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy.

Journal: HIV medicine

Published: May 22, 2024

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Journal: Open forum infectious diseases

Published: August 21, 2023

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa.

Journal: British journal of clinical pharmacology

Published: August 17, 2023

Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic Pain.

Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic Pain.

Journal: AIDS and behavior

Published: November 06, 2022

Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: January 31, 2022

Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020.

Corrigendum: Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020.

Journal: Southern African journal of HIV medicine

Published: December 27, 2021

Gastrointestinal manifestations of human immunodeficiency virus and coronavirus disease 2019: Understanding the intersecting regions between the two epidemics.

Gastrointestinal manifestations of human immunodeficiency virus and coronavirus disease 2019: Understanding the intersecting regions between the two epidemics.

Journal: Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology

Published: December 11, 2020

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa.

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa.

Journal: Journal of the International AIDS Society

Published: November 13, 2020

Showing 1-12 of 49

Last Updated: 09/26/2026